Democrats in the US House of Representatives began what they said would be a wide-ranging investigation into how the US pharmaceutical industry sets prices, moving quickly on an issue where there appears to be accord with the White House.
The US House Committee on Oversight and Reform asked for detailed information about pricing practices from a dozen companies on specific medications, including bestsellers such as AbbVie Inc’s Humira and Amgen Inc’s Enbrel, which are used to treat autoimmune diseases; Pfizer Inc’s pain drug Lyrica; and Sanofi SA’s diabetes treatment Lantus.
Also under scrutiny are medications available in generic formulations, including AstraZeneca PLC’s cholesterol medicine Crestor and Teva Pharmaceuticals Industries Ltd’s multiple sclerosis treatment Copaxone.
“For years, drug companies have been aggressively increasing prices on existing drugs and setting higher launch prices for new drugs while recording windfall profits,” committee chairman Elijah Cummings said. “The goals of this investigation are to determine why drug companies are increasing prices so dramatically, how drug companies are using the proceeds and what steps can be taken to reduce prescription drug prices.”
Drug manufacturers have been under increasing pressure over the cost of their medications. In the past week, US lawmakers on both sides of the aisle have proposed legislation to rein in drug prices.
The pressure has not yet curtailed soaring costs, as drug companies have in the past few weeks boosted US list prices on hundreds of treatments.
Pharmaceutical companies have defended their practices by saying the cost of developing new therapies is high. Some drugmakers have promised to try to increase transparency around drug costs by posting more information about their pricing practices online, among other measures.
The desire to contain high prescription drug costs is a rare area of partisan agreement in Washington.
US Secretary of Health and Human Services Alex Azar last week tweeted that “prices must come down,” praising Merck & Co, Gilead Sciences Inc and Amgen for lower prices.
Neither Merck nor Gilead were sent letters by the committee, according to a list posted on the panel’s Web site.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”